Anemia, characterized by a decrease in the number of circulating red blood cells (RBCs) or a reduction in their oxygen-carrying capacity, is a common clinical presentation with a myriad of potential causes. Its diagnosis can often be complex, necessitating a systematic and comprehensive approach.
The first step in diagnosing anemia is a thorough history and physical examination. This should include inquiries about symptoms, family history, dietary habits, and potential exposures. The physical examination should focus on signs of anemia and its potential causes.
Initial laboratory evaluation for anemia typically includes a complete blood count (CBC) and a reticulocyte count. The CBC provides information about the size (MCV) and hemoglobin content (MCH, MCHC) of the RBCs, which can help categorize the anemia as microcytic, normocytic, or macrocytic. The reticulocyte count indicates the bone marrow's response to anemia.
If the initial tests do not provide a clear diagnosis, further testing may be necessary. This may include serum iron studies, vitamin B12 and folate levels, hemoglobin electrophoresis, and bone marrow examination, among others. The choice of additional tests depends on the clinical context and the findings from the initial evaluation.
The treatment of anemia depends on its cause. For example, iron deficiency anemia is typically treated with iron supplementation, while vitamin B12 deficiency anemia requires B12 supplementation. In some cases, treating the underlying cause of the anemia (such as a bleeding ulcer) may resolve the anemia.
In conclusion, the diagnostic approach to anemia involves a comprehensive history and physical examination, initial laboratory evaluation, and potentially additional diagnostic tests. Understanding this process is essential for healthcare professionals to accurately diagnose and manage this common condition.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation